Clinical Trials Logo

Filter by:
NCT ID: NCT00615394 Completed - Clinical trials for Dilated Cardiomyopathy

Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells by Mini-Thoracotomy

STEMDILCARD
Start date: April 2004
Phase: Phase 1/Phase 2
Study type: Interventional

Bone marrow mononuclear cells (BMMC) transplantation is a promising therapy for treating ischemic disease, however the effect in non-ischemic dilated cardiomyopathy is unknown.This study describes a technique of BMMC transplantation utilizing mini-thoracotomy and results up to one year after the procedure.

NCT ID: NCT00615316 Completed - Fatigue Clinical Trials

Guaraná for Radiation Related Fatigue in Breast Cancer Patients

Start date: December 2006
Phase: Phase 2
Study type: Interventional

We hypothesize that Guaraná, a native plant from the Amazon, might improve radiation-induced fatigue in breast cancer patients undergoing treatment. In order to assess this, we randomized patients to either guaraná extract or to placebo, switching the assigned treatment mid-term through the radiation.

NCT ID: NCT00614211 Completed - Cervical Cancer Clinical Trials

Laparoscopic Approach to Cervical Cancer

LACC
Start date: January 2008
Phase: N/A
Study type: Interventional

The goal of this clinical research study is to compare the long-term outcomes of different surgical methods for the treatment of cervical cancer. The long-term outcome of a total abdominal radical hysterectomy (TARH) will be compared against laparoscopy. In this study, the laparoscopy will be done with or without robotic technology.

NCT ID: NCT00612469 Completed - Dental Caries Clinical Trials

The Use of Antimicrobial Agents in the Inhibition of Mutans Streptococci in Children With Dental Caries

Start date: October 2005
Phase: N/A
Study type: Interventional

The aim of the present study was to compare salivary MS levels in four different groups of children with caries, that have been submitted to intraoral topical treatment with either 1,23% sodium fluoride, 1% chlorhexidine, 3% or 10% vancomycin, during 6 consecutive days. This clinical trial was designed to test two different hypotheses. First, that topical vancomycin would be more effective than chlorhexidine and sodium fluoride in salivary MS reduction. Secondly, a 6-day antimicrobial treatment with either one of these agents would produce a long lasting MS suppression, dispensing repeated antibacterial treatments.

NCT ID: NCT00611364 Completed - Hypertension Clinical Trials

Physical Therapy for Hypertensive Elderly

Start date: March 2004
Phase: Phase 4
Study type: Interventional

Physical therapy for hipertensive elderly: effects in the physical activity and exercise adherence. Introduction: The arterial hypertension (AH) is a clinical syndrome characterized by blood pressure ≥ 140/90mmHg. Practical of physical activity (PA) and/or physical exercise (PE) is one of the modalities of not farmacological treatment. Hypertensive aged not adhere to this recommendation for presenting factors that make it difficult this practical. Objective: to verify if physical therapy (PT) treatment can improve the AF and EF adhesion of hypertensive aged. Methods: The sample was composed by 43 hypertensive aged of Arterial Hypertensive League of the Federal University of Goiás. Of these, 30 had remained in the study and had been randomized in study group (SG) (16 patients) and control group (CG) (14 patients). SG was submitted of the PT treatment and participated of educative meetings, the CG only participated of the meetings. To evaluate adhesion to the AF was used the pedometer and EF was used a questionnaire of open and closed questions, six minute walk test (6`WT) and ergometric test (ET).

NCT ID: NCT00611026 Completed - Overactive Bladder Clinical Trials

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.

Start date: February 2008
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy and safety of fesoterodine in comparison to tolterodine and placebo for overactive bladder

NCT ID: NCT00610545 Completed - Vascular Surgery Clinical Trials

Atorvastatin in Perioperative Vascular Surgery - Pilot Study

APVS
Start date: July 2007
Phase: Phase 4
Study type: Interventional

This study is designed to determine if the use of atorvastatin (Lipitor), a member of the HMG coA reductase inhibitor class of drugs referred to as statins, will reduce cardiovascular outcomes ( mortality - myocardial infarction - stroke ) when given in high doses in comparative standard doses in the perioperative period of major vascular surgery. Abdominal aortic aneurysm , Carotid endarterectomy , Revascularization of lower limbs

NCT ID: NCT00610272 Completed - Pain Clinical Trials

Optimization of Radiotherapy in Treatment of Painful Bone Metastasis

bone mets
Start date: January 2008
Phase: Phase 3
Study type: Interventional

Bone metastasis is one of the most frequent end complications of the cancer. Radiation therapy is the mainstay of treatment in this disease. Single fraction radiotherapy in both single and multiple bone metastasis is widely used, but optimization of the single dose fractionation is needed. Two different regimens of radiotherapy dose fractionation will be investigated in both single and multiple bone metastasis and endpoints will include pain relief as well as toxicity and quality of life.

NCT ID: NCT00608569 Completed - HIV Infections Clinical Trials

Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults

Start date: March 2009
Phase: N/A
Study type: Interventional

Highly active antiretroviral therapy (HAART) has led to better health and survival rates among people with HIV/AIDS. The purpose of this study was to measure the effect of trained partner supervision when taking medication versus self-administered therapy in HIV infected participants. These participants have had their first virologic failure on a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based HAART regimen and were starting a protease inhibitor (PI)-based HAART regimen at study entry.

NCT ID: NCT00607386 Completed - Clinical trials for Mucopolysaccharidosis II

Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy

Start date: December 31, 2007
Phase: Phase 4
Study type: Interventional

The objective of this study is to determine the safety of once weekly dosing of idursulfase 0.5 mg/kg administered by intravenous (IV) infusion for male Hunter syndrome patients ≤ 5 years old.